Docusign (DOCU)
(Delayed Data from NSDQ)
$57.44 USD
+0.74 (1.31%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $57.44 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$57.44 USD
+0.74 (1.31%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $57.44 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth D Momentum B VGM
Zacks News
Why DocuSign (DOCU) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
AppLovin Corporation (APP) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
AppLovin (APP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Investors Heavily Search Docusign Inc. (DOCU): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to DocuSign (DOCU). This makes it worthwhile to examine what the stock has in store.
Reasons to Retain Insperity (NSP) Stock in Your Portfolio Now
by Zacks Equity Research
Insperity (NSP) relies on its diversified revenue base to mitigate market risks.
DocuSign (DOCU) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
The latest trading day saw DocuSign (DOCU) settling at $56.87, representing a -0.56% change from its previous close.
Here's Why You Should Retain Accenture (ACN) Stock for Now
by Zacks Equity Research
Accenture's (ACN) disciplined acquisition strategy focuses on channeling its business in high-growth areas, adding skills and capabilities, and deepening industry and functional expertise.
Here's Why You Should Retain IQVIA (IQV) Stock for Now
by Zacks Equity Research
IQVIA (IQV) rides high on robust segmental performance, boosting the company's top line. However, elevated operating expenses and weak liquidity are a major concern.
Bakkt Holdings, Inc. (BKKT) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Bakkt (BKKT) delivered earnings and revenue surprises of -50.85% and 41.87%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Amprius Technologies (AMPX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Amprius (AMPX) delivered earnings and revenue surprises of -18.18% and 36.48%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why DocuSign (DOCU) Outpaced the Stock Market Today
by Zacks Equity Research
DocuSign (DOCU) concluded the recent trading session at $50.58, signifying a +1.71% move from its prior day's close.
Here is What to Know Beyond Why Docusign Inc. (DOCU) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching DocuSign (DOCU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why DocuSign (DOCU) Outpaced the Stock Market Today
by Zacks Equity Research
In the most recent trading session, DocuSign (DOCU) closed at $55.90, indicating a +1.45% shift from the previous trading day.
DocuSign (DOCU) Laps the Stock Market: Here's Why
by Zacks Equity Research
The latest trading day saw DocuSign (DOCU) settling at $56.62, representing a +1.31% change from its previous close.
DocuSign (DOCU) Dips 12% in 6 Months: Is the Stock Worth Buying?
by Shuvra Shankar Dey
Given the recent decline in DocuSign (DOCU) shares, we evaluate the stock's current position to determine whether it presents a good investment opportunity at this time.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Docusign Inc. (DOCU) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching DocuSign (DOCU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DocuSign (DOCU) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
In the closing of the recent trading day, DocuSign (DOCU) stood at $57.14, denoting a +1.34% change from the preceding trading day.
Reasons to Hold DocuSign (DOCU) Stock in Your Portfolio Now
by Zacks Equity Research
DocuSign (DOCU) is experiencing improved performance with customers managed by the direct sales force.
DocuSign (DOCU) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
DocuSign (DOCU) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching DocuSign (DOCU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why You Should Add AppFolio (APPF) Stock to Your Portfolio Now
by Zacks Equity Research
AppFolio (APPF) benefits from AI investments, giving it a competitive advantage.
DocuSign (DOCU) Stock Declines 6.6% Despite Q1 Earnings Beat
by Zacks Equity Research
DocuSign's (DOCU) top and bottom lines increase year over year in the first quarter of fiscal 2025.
DocuSign (DOCU) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for DocuSign (DOCU) give a sense of how the business performed in the quarter ended April 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.